The procured ProEmpower solution will address the need for the stratification of patients according to risk and promote the adoption of a team-based approach. Care will become person centred, guided by a personalised decision support system which will make it easier to set adequate treatment goals based on weighing in multiple factors. Self-management education will be a key component of the ProEmpower solution which will foster the creation of a peer support network for patients, in order to help them maintain a healthier lifestyle. At the same time, ProEmpower will contribute to creating a learning healthcare system based in a quality oriented culture that continuously improves itself.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected operator will be awarded a framework agreement that covers three R&D phases. The three phases are: solution design, prototyping, original development, and validation and testing of a limited set of first products or services. After each phase, intermediate evaluations will be carried out to select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
For further information and tender documents, please visit:
ProEmpower receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 727409.